LeMaitre Vascular, Inc. (LMAT)
NASDAQ: LMAT · IEX Real-Time Price · USD
65.46
+2.47 (3.92%)
Apr 26, 2024, 4:00 PM EDT - Market closed

LeMaitre Vascular Revenue

In the year 2023, LeMaitre Vascular had annual revenue of $193.48M with 19.69% growth. Revenue in the quarter ending December 31, 2023 was $48.88M with 19.36% year-over-year growth.

Revenue (ttm)
$193.48M
Revenue Growth
+19.69%
P/S Ratio
7.53
Revenue / Employee
$307,117
Employees
630
Market Cap
1.46B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023193.48M31.83M19.69%
Dec 31, 2022161.65M7.23M4.68%
Dec 31, 2021154.42M25.06M19.37%
Dec 31, 2020129.37M12.13M10.35%
Dec 31, 2019117.23M11.66M11.05%
Dec 31, 2018105.57M4.70M4.66%
Dec 31, 2017100.87M11.72M13.14%
Dec 31, 201689.15M10.80M13.78%
Dec 31, 201578.35M7.26M10.20%
Dec 31, 201471.10M6.55M10.14%
Dec 31, 201364.55M7.81M13.77%
Dec 31, 201256.74M-950.00K-1.65%
Dec 31, 201157.69M1.63M2.90%
Dec 31, 201056.06M5.15M10.12%
Dec 31, 200950.91M2.19M4.49%
Dec 31, 200848.72M7.27M17.55%
Dec 31, 200741.45M6.82M19.69%
Dec 31, 200634.63M3.90M12.70%
Dec 31, 200530.73M4.54M17.35%
Dec 31, 200426.18M5.52M26.71%
Dec 31, 200320.66M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
National HealthCare 1.14B
InMode 492.05M
Veracyte 361.05M
Dynavax Technologies 232.28M
Arcus Biosciences 117.00M
Gyre Therapeutics 113.45M
Protagonist Therapeutics 60.00M
Revenue Rankings